FDA Proposes Dangerous Vaccine Rule Change, 6-21-2010, National Vaccine Information Center, NVIC, Barbara Loe Fisher
source: daily mail
by: Fiona Macrae
source: Natural News
by: Mike Adams
by: Andrew Hough
Swiss researchers claimed allergies that blight the lives of 10 million British sufferers could be largely eradicated with a single vaccine.
An allergy conference in London heard the “one size fits all” injection that wards off asthma, eczema, hay fever and even peanut allergies could be on the shelves within four to five years.
Experts say if the jab, known only as CYT003-Qbg10 which has been tested on humans, is properly developed it becomes the “hail grail” of vaccines due to it helping ward off multiple allergies.
by: Veronica Martin
source: the epoch times
by: Dr. John Briffa
Source: Natural News
A stunning new report reveals that top scientists who convinced the World Health Organization (WHO) to declare H1N1 a global pandemic held close financial ties to the drug companies that profited from the sale of those vaccines. This report, published in the British Medical Journal, exposes the hidden ties that drove WHO to declare a pandemic, resulting in billions of dollars in profits for vaccine manufacturers.
Several key advisors who urged WHO to declare a pandemic received direct financial compensation from the very same vaccine manufacturers who received a windfall of profits from the pandemic announcement. During all this, WHO refused to disclose any conflicts of interests between its top advisors and the drug companies who would financially benefit from its decisions.
All the kickbacks, in other words, were swept under the table and kept silent, and WHO somehow didn't think it was important to let the world know that it was receiving policy advice from individuals who stood to make millions of dollars when a pandemic was declared.
source: Daily Mail
by: Jo Macfarlane
Department of Health officials are understood to be investigating whether the vaccine can be bought at a price to make the plan ‘cost-effective’.
The recommendation – which has not been triggered by any specific concern – was made by the Joint Committee
on Vaccination and Immunisation (JCVI) at its meeting last October.
All recommendations by the JCVI based on cost-effectiveness must be implemented and funded by the Government.
The minutes of its meeting stated that the Herpes zoster [shingles] vaccination should be introduced to people aged between 70 and 79. ‘This age group was proposed as the duration of protection, based on current data, is estimated to be 7.5 years and infection is more severe and the burden of illness is greater in this age group,’ it was stated.
by: The Daily Bell
by: Barbara Loe Fisher